by Leah Price (Ben-Porat)
Moher D, Soeken K, Sampson M, Ben-Porat L, Berman B. Assessing the quality of reports of systematic reviews in pediatric complementary and alternative medicine, BMC Pediatrics (2002) 2:3 (27 Feb 2002).
Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in Perioperative Outcome after Hepatic Resection: Analysis of 1803 Consecutive Cases. Annals of Surgery 2002; 236 (4) 397-407.
Allen PJ, Stojadinovic A, Ben-Porat L, Gonen M, Kooby D, Blumgart L, Paty P, Fong Y. The management of variant arterial anatomy during hepatic arterial infusion pump placement. Annals of Surgical Oncology. 2002 Nov-Dec;9(9):875-80.
Stephen F. Stanziale, MD, Henrik Petrowsky, MD, John K. Joe, MD, Gretchen D. Roberts, PhD, Jonathan S. Zager, MD, Niraj J. Gusani, MD, Leah Ben-Porat, MS, Mithat Gonen, PhD, Yuman Fong, MD. Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase. Surgery 2002 Aug;132(2):353-9.
Gary A. Ulaner, Hsuan-Ying Huang, Jesse Otero, Leah Ben-Porat, Jaya M. Satagopan, Zhiquan Zhao, Richard Gorlick, Paul Meyers, John H. Healey, Andrew G. Huvos, Andrew R. Hoffman, and Marc Ladanyi. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Research 2003 Apr 15;63(8):1759-63.
Zelefsky MJ, Yamada Y, Marion C, Sim S, Cohen G, Ben-Porat L, Silvern D, Zaider M. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003 Mar 15;55(4):956-63.
Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Annals of Surgery. 2003 Jun;237(6):860-70.
Orit Yossepowitch, Narciso Olvera, Jaya M. Satagopan, Helen Huang, Sabrina Jhanwar, Leah Ben-Porat, Beth Rapaport, Jeff Boyd, Kenneth Offit. BRCA1 and BRCA2 Germline Mutations in Lymphoma Patients. Leukemia and Lymphoma, 2003 Vol. 44 (1), pp. 127–131.
Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. JNCI. 2003;95:1718-1721.
Wagner JE, Tolar J, Levran O, Scholl T, Deffenbaugh A, Satagopan J, Ben-Porat L, Mah K, Batish SD, Kutler DI, MacMillan ML, Hanenberg H, Auerbach AD. Germline Mutations in BRCA2: Shared Genetic Susceptibility to Breast Cancer, Early Onset Leukemia and Fanconi Anemia. Blood. 2004 Apr 15;103(8):3226-9. Epub 2004 Jan 08.
Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Annals of Surgical Oncology. 2004 Mar-Apr;11(3):310-5.
Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol. 2004 Mar 15;22(6):1103-9.
Adusumilli P, Ben-Porat L, Pereira M, Roesler D, Leitman IM. The Prevalence and Predictors of Herbal Medicine Use in Surgical Patients. Journal of American College of Surgeons. 2004 Apr;198(4):583-90.
Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML. Costs Of Treatment And Outcomes Associated With Second- Line Therapy And Greater For Relapsed Ovarian Cancer. Gynecologic Oncology, 2004 Apr;93(1):223-8.
Stanziale SF, Petrowsky H, Adusumilli PS, Ben-Porat L, Gonen M, Fong Y. Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity. Clin Cancer Res. 2004 May 1;10(9):3225-32.
Janetzki S, Schaed S, Blachere NEB, Ben-Porat L, Houghton AN, Panageas K. Evaluation of Elispot assays: Influence of method and operator on variability of results. Journal Of Immunological Methods, 2004 August;291(1):175-83.
Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. British Journal of Cancer, 2004 Oct 4;91(7):1229-35.
Shah NT, Kris MG, Miller VA, Tyson LB, Pizzo BM, Heinemann M-H, Ben Porat L, Halpern A, Heelan RT. Practical management of patients with non-small cell lung cancer treated with Gefitinib (IressaTM, ZD1839). J Clin Oncol, 2005 Jan 1;23(1):165-74.
Pothuri B, Montemarano M, Gerardi M, Shike M, Ben-Porat L, Sabbatini P, Barakat RR. Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement in Patients with Malignant Bowel Obstruction Due To Ovarian Carcinoma. Gynecol Oncol, 2005 Feb;96(2):330-334.
Zelefsky MJ, Ben-Porat L, Scher HI, Chan HM, Fearn PA, Fuks ZY, Leibel SA, Venkatraman ES. Outcome Predictors for the Increasing PSA State After Definitive External-Beam Radiotherapy for Prostate Cancer. J Clin Oncol. 2005 Feb 1;23(4):826-31.
Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Barnhill R. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005 Feb 2;97(3):195-9.
Zaider M, Zelefsky MJ, Cohen GN, Chui C, Yorke ED, Ben-Porat L Happersett L. Methodology for biologically-based treatment planning for combined low dose-rate (permanent implant) and high dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):702-13.
Hale E, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, Osman I, Kopf AW, Polsky D. Association of Melanoma and Neurocutaneous Melanocytosis with Large Congenital Melanocytic Naevi – Results from the NYU-LCMN Registry. British Journal of Dermatology 2005 Mar 152 (3): 512-517.
Hawkins WG, Busam KJ, Ben-Porat L, Panageas KS, Coit DG, Gyorki DE, Linehan DC, Brady MS. Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma. Ann Surg Oncol. 2005 Mar;12(3):207-13.
Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, Dematteo RP, D'angelica M, Koea J, Blumgart LH. Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma. Ann Surg. 2005 May;241(5):703-714.
Bowne WB, Lee B, Ben-Porat L, Paty PB, Guillem JG, Cohen AM, Enker W, Wong WD, Weiser MR. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum. 2005 May;48(5):897-909.
Allen PJ, Nissan A, Picon AI, Kemeny N, Dudrick P, Ben-Porat L, Espat J, Stojadinovic A, Cohen AM, Fong Y, Paty PB. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005 Jul;201(1):57-65.
Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Barnhill R. RESPONSE: Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst author reply, J Natl Cancer Inst. 2005 Aug 3; 97(15):1159-60.
Ghazinouri R, Levy C, Ben-Porat L, Stubblefield MD. Shoulder Impairments in Patients with Breast Cancer: a Retrospective Review. Rehabilitation Oncology. 2005 Aug; 23 (2):5-8.
Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK, Ben-Porat L, Minsky BD, Cohen AM, Paty PB. T1 Adenocarcinoma of the Rectum: Transanal Excision or Radical Surgery? Ann Surg. 2005 Oct;242(4):472-479.
Ferrone CR, Ben-Porat L, Panageas KS, Berwick M, Halpern AC, Patel A, Coit DG. Multiple Primary Melanomas: Clinicopathologic Features and Risk Factors in 385 Patients. JAMA. 2005 Oct 5;294(13):1647-54.
Adusumilli PS, Chan MK, Ben-Porat L, Mullerad M, Stiles BM, Tuorto S, Fong Y. Citation characteristics of basic science research publications in general surgical journals. J Surg Res. 2005 Oct;128(2):168-73.
Omuro AMP, Ben-Porat L, Panageas KS, Kim AK, Correa DD, Yahalom J, DeAngelis LM, Abrey LE. Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol. 2005 Oct;62(10):1595-600.
Adusumilli PS, Eisenberg DP, Chun YS, Ryu KW, Ben-Porat L, Hendershott KJ, Chan MK, Huq R, Riedl C, Fong Y. Virally-directed Fluorescent Imaging (VFI) Improves Diagnostic Sensitivity in the Detection of Minimal Residual Disease Following Potentially Curative Cytoreductive Surgery. J Gastrointest Surg. 2005 Nov-Dec;9(8):1138-47.
Panageas KS, Elkin EB, DeAngelis LM, Ben-Porat L, Abrey LE. Trends in Survival from Primary Central Nervous System Lymphoma 1975-1999: A Population-based Analysis. Cancer. 2005 Dec 1;104(11):2466-72.
Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit G. Estimates of Stage Specific Survival are Altered by the Changes in the 2002 AJCC Staging for Melanoma. Cancer. 2006 Jan 1;106(1):163-71.
D'Angelica M, Maddineni S, Fong Y, Martin RCG, Cohen MS, Ben-Porat L, Gonen M, DeMatteo RP, Blumgart LH, Jarnagin WR. Optimal Abdominal Incision for Partial Hepatectomy: Increased Late Complications with Mercedes-type Incisions Compared to Extended Right Subcostal Incisions. World J Surg. 2006 Mar;30(3):410-418.
Adusumilli PS, Stiles BM, Chan MK, Mullerad M, Eisenberg DP, Ben-Porat L, Huq R, Rusch VW, Fong Y. Imaging and Therapy of Malignant Pleural mesothelioma using Replication-competent Herpes Simplex Viruses. J Gene Med 2006; 8: 603–615.
Covey AM, Maluccio MA, Schubert J, Ben-Porat L, Brody LA, Sofocleous CT, Getrajdman GI, Fong Y, Brown KT. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer. 2006 May 15;106(10):2181-9.
Dalbagni G, Russo P, Bochner B, Ben-Porat L, Sheinfeld J, Sogani P, Donat MS, Herr HW, Bajorin D. Phase II Trial of Intravesical Gemcitabine in Bacille Calmette-Guerin-Refractory Transitional Cell Carcinoma of the Bladder. J Clin Oncol. 2006 Jun 20;24(18):2729-34.
Zelefsky MJ, Ben-Porat L, Chan HM, Fearn PA, Venkatraman ES. Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):382-8.
Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, Deangelis LM. Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model. J Clin Oncol. 2006 Dec 20;24(36):5711-5.
Dalbagni G, Parekh DJ, Ben-Porat L, Potenzoni M, Herr HW, Reuter VE. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder. BJU Int. 2007 Feb;99(2):281-5.
Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D. When you look matters: the effect of assessment schedule on progression-free survival. J Natl Cancer Inst. 2007 Mar 21;99(6):428-32.
Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE. Patterns of treatment in older adults with primary central nervous system lymphoma. Cancer. 2007 Sep 15;110(6):1338-44.
Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res. 2007 Oct 1;67(19):9591-6.
Wright JL, Cordeiro PG, Ben-Porat L, Van Zee KJ, Hudis C, Beal K, McCormick B. Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):43-50.
Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Martin Kast W, Hoos A; for the Elispot Proficiency Panel of the CVC Immune Assay Working Group. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother. 2008 Mar;57(3):303-15. Epub 2007 Aug 25.
Maluccio MA, Covey AM, Ben-Porat L, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, Jarnagin W, Dematteo R, Blumgart LH, Fong Y, Brown KT. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2008 Jun;19(6):862-9. Epub 2008 Apr 10
Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer. 2008 Sep 1;113(5):1025-31.
Rengan R, Pfister DG, Lee NY, Kraus DH, Shah JP, Shaha AR, Ben-Porat LS, Zelefsky MJ. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol. 2008 Oct;31(5):465-9.
Fuchsjäger MH, Pucar D, Zelefsky MJ, Zhang Z, Mo Q, Ben-Porat LS, Shukla-Dave A, Wang L, Reuter VE, Hricak H. Predicting Post-External Beam Radiation Therapy PSA Relapse of Prostate Cancer Using Pretreatment MRI. Int J Radiat Oncol Biol Phys. 2010 Feb 2.
Britten CM, Janetzki S, Ben-Porat L, Clay TM, Kalos M, Maecker H, Odunsi K, Pride M, Old L, Hoos A, Romero P; HLA-peptide Multimer Proficiency Panel of the CVC-CRI Immune Assay Working Group. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol Immunother. 2009 Oct;58(10):1701-13.
Janetzki S, Price L, Britten CM, van der Burg SH, Caterini J, Currier JR, Ferrari G, Gouttefangeas C, Hayes P, Kaempgen E, Lennerz V, Nihlmark K, Souza V, Hoos A. Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother. 2010 Apr;59(4):609-18.
Sethi RA, Stamell EF, Price L, DeLacure M, Sanfilippo N. Head and neck radiotherapy compliance in an underserved patient population. Laryngoscope. 2010 Jul;120(7):1336-41.
Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Löwer M, Welters MJ, Ottensmeier C, van der Burg SH, Britten CM. Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother. 2010 Oct;59(10):1489-501.
Wich LG, Ma MW, Price LS, Sidash S, Berman RS, Pavlick AC, Miller G, Sarpel U, Goldberg JD, Osman I. Impact of Socioeconomic Status and Sociodemographic Factors on Melanoma Presentation Among Ethnic Minorities. J Community Health. 2010 Nov 16.
Adusumilli PS, Gholami S, Chun YS, Mullerad M, Chan MK, Yu Z, Ben-Porat L, Rusch VW, Fong Y. Fluorescence-assisted cytological testing (FACT): Ex Vivo viral method for enhancing detection of rare cancer cells in body fluids. Mol Med. 2011;17(7-8):628-34.
Attig S, Price L, Janetzki S, Kalos M, Pride M, McNeil L, Clay T, Yuan J, Odunsi K, Hoos A, Romero P, Britten CM; CRI-CIC Assay Working Group. A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols. J Transl Med. 2011 Jul 11;9:108.
Moodie Z, Price L, Janetzki S, Britten CM. Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories. Methods Mol Biol. 2012;792:185-96.
Hwa C, Price LS, Belitskaya-Levy I, Ma MW, Shapiro RL, Berman RS, Kamino H, Darvishian F, Osman I, Stein JA. Single versus multiple primary melanomas: old questions and new answers. Cancer. 2012 Sep 1;118(17).
McNeil LK, Price L, Britten CM, Jaimes M, Maecker H, Odunsi K, Matsuzaki J, Staats JS, Thorpe J, Yuan J, Janetzki S. A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI). Cytometry A. 2013 Aug;83(8):728-38.